Cardiac biomarkers are the substances that are released into the bloodstream when the heart is stressed or damaged. Suppression of tumorigenicity 2 (ST2) is one such biomarker used to help in measurement of heart failure risk to assess the treatment options. The ST2 biomarker is a member of the interleukin-1 receptor family biomarker. It is a strong predictor and most promising biomarker for both chronic and acute heart failure.
ST2 was first discovered in 1989, but in 2002 it was known to be expressed by cardiac cells in response to myocardial stress. Unlike other cardiac biomarkers, the level of ST2 in the blood is found the best to help physicians for making decisions for an appropriate action to take and quickly adjust the treatment.
The level of ST2 is quickly changed with the heart conditions of the patients which makes it as a best cardiac biomarker to monitor the progress of the heart treatment. According to the centre for disease control and prevention (CDC), heart disease is the leading cause of death for people in the United States, including African Americans, Hispanics, and whites.
Besides, heart disease is found as the second cause of death in American Indians or Alaska Natives and Asians or Pacific Islanders. However, it is observed that more clinicians are now turning to use ST2 biomarker unlike other biomarkers to help and guide treatment of heart failure of patients. Recently, the Presage ST2 assay has been approved by regulatory agencies in Europe and the United States for prognostication in Heart failure.
Moreover, due to the low-biological variability, ST2 biomarker considered as an ideal biomarker to monitor heart disease. It helps to monitor the risk of heart failure and guide in hospital and post-discharge care of the heart patients.
Increasing prevalence and incidence of heart diseases drives the ST2 biomarker market. Unlike other biomarkers, ST2 biomarker is considered as an ideal biomarker to monitor heart disease because of the low-biological variability, which drives the market of ST2 biomarker.
Nowadays, the rising heart diseases due to physical inactivity and unhealthy diet are the main factors drives the ST2 biomarker market. However, due to unavailability of sufficient systems/products for the detection of ST2 biomarker and lack of awareness about the use of ST2 biomarker among the clinicians expected to restrain the ST2 biomarker market.
According to WHO, 17.9 Mn people are dying due to cardiovascular diseases each year, which is approximately 31% of all death worldwide. Consequently, as a novel biomarker for the detection of heart diseases the market of ST2 biomarker will expectedly grow tremendously during forecasting periods.
The ST2 biomarker detection will provide immense opportunities among the key players to develop novel ST2 biomarker detection kits and devices in the upcoming periods. The rising death rate due to heart diseases expected to grow the market of ST2 biomarker globally.
The in time result of ST2 level by the ELISA assay helps physicians to control and manage the heart patients, which is expected to help in the growth of global ST2 biomarker market.
The U.S. is expected as the leading market of ST2 biomarker due to the increasing prevalence and death of heart disease in this region. The market of ST2 biomarker is high in the U.S. also because of the greater degree of awareness among the individuals and high economy followed by Europe.
The high growth of the ST2 biomarker market has also been observed in Asia Pacific countries due to the increasing number of death due to heart diseases and awareness among the people.
Prominent growth of ST2 biomarker market has been expected from the emerging countries such as China, India, Brazil and South Africa in the forecast years that will provide a huge opportunity to lunch new product among the market players.
Examples of some of the key market participants operating in the ST2 biomarker market are Thermo Fisher Scientific, Inc., Critical Care Diagnostics, Inc., Diagnostic Automation/Cortez Diagnostics, Inc., MyBioSource, Inc., San Diego, CA. Elabscience Biotechnology, Inc. among others.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors, along with market attractiveness as per segment.
The report also maps the qualitative impact of various market factors on market segments and geographies.
Based on techniques used, the ST2 biomarker market can be segmented as:
Based on product types, the ST2 biomarker market can be segmented as:
Based on disease types, the ST2 biomarker market can be segmented as:
Based on the end-user, the ST2 biomarker market can be segmented as:
Our Research Products
The "Full Research Suite" delivers actionable market intel, deep dives on markets or technologies, so clients act faster, cut risk, and unlock growth.
The Leaderboard benchmarks and ranks top vendors, classifying them as Established Leaders, Leading Challengers, or Disruptors & Challengers.
Locates where complements amplify value and substitutes erode it, forecasting net impact by horizon
We deliver granular, decision-grade intel: market sizing, 5-year forecasts, pricing, adoption, usage, revenue, and operational KPIs—plus competitor tracking, regulation, and value chains—across 60 countries broadly.
Spot the shifts before they hit your P&L. We track inflection points, adoption curves, pricing moves, and ecosystem plays to show where demand is heading, why it is changing, and what to do next across high-growth markets and disruptive tech
Real-time reads of user behavior. We track shifting priorities, perceptions of today’s and next-gen services, and provider experience, then pace how fast tech moves from trial to adoption, blending buyer, consumer, and channel inputs with social signals (#WhySwitch, #UX).
Partner with our analyst team to build a custom report designed around your business priorities. From analysing market trends to assessing competitors or crafting bespoke datasets, we tailor insights to your needs.
Supplier Intelligence
Discovery & Profiling
Capacity & Footprint
Performance & Risk
Compliance & Governance
Commercial Readiness
Who Supplies Whom
Scorecards & Shortlists
Playbooks & Docs
Category Intelligence
Definition & Scope
Demand & Use Cases
Cost Drivers
Market Structure
Supply Chain Map
Trade & Policy
Operating Norms
Deliverables
Buyer Intelligence
Account Basics
Spend & Scope
Procurement Model
Vendor Requirements
Terms & Policies
Entry Strategy
Pain Points & Triggers
Outputs
Pricing Analysis
Benchmarks
Trends
Should-Cost
Indexation
Landed Cost
Commercial Terms
Deliverables
Brand Analysis
Positioning & Value Prop
Share & Presence
Customer Evidence
Go-to-Market
Digital & Reputation
Compliance & Trust
KPIs & Gaps
Outputs
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Biomarker-based Immunoassays Market Size and Share Forecast Outlook 2025 to 2035
Global Biomarker Discovery Outsourcing Service Market Analysis – Size, Share & Forecast 2024-2034
EPO Biomarkers Market Size and Share Forecast Outlook 2025 to 2035
Dual Biomarker Assays Market Analysis - Size, Share, & Forecast Outlook 2025 to 2035
PD-L1 Biomarker Testing Market Report – Demand, Trends & Forecast 2025–2035
Brain Biomarker Market Trends and Forecast 2025 to 2035
Market Share Breakdown of PD-L1 Biomarker Testing Manufacturers
Renal Biomarker Market Report – Trends & Forecast 2024-2034
Vitamin Biomarkers Market Size and Share Forecast Outlook 2025 to 2035
Cardiac Biomarker Diagnostic Test Kits Market Analysis – Trends & Forecast 2025 to 2035
Multiplex Biomarker Imaging Market Forecast and Outlook 2025 to 2035
Molecular Biomarkers For Cancer Detection Market Size and Share Forecast Outlook 2025 to 2035
Prognostic Biomarkers Market
Blood-based Biomarker For Alzheimer's Disease Diagnostics Market Size and Share Forecast Outlook 2025 to 2035
Key Players & Market Share in the Blood-Based Biomarker Industry
Neurological Biomarkers Market Size and Share Forecast Outlook 2025 to 2035
Predisposition Biomarkers Market Size and Share Forecast Outlook 2025 to 2035
Asthma and COPD Biomarkers Market
Multiplex Sepsis Biomarker Panels Market Size and Share Forecast Outlook 2025 to 2035
Global Advanced At-home Biomarker Testing Market Analysis – Size, Share & Forecast 2024-2034
ST2 Biomarker Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
